Patent EP0001929A2 successfully refreshed from Google Patents.
← Back to Patent Explorer
US5332671A Expired / Lapsed US ⏱️ 0.0 years remaining

Production of vascular endothelial cell growth factor and DNA encoding same

Assignee: Genentech Inc
•
Filing: 1989-08-04
•
Granted: 1994-07-26
•
Expires: 2009-08-04
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract DNA isolates coding for a vascular endothelial cell growth factor may be used to produce the protein via recombinant expression systems. Such protein is useful therapeutically to treat conditions in which a selective action on the vascular endothelial cells, in the absence of excessive connective tissue proliferation, is desirable.

Inventors

  • 👤 Napoleone Ferrara
  • 👤 David W.-H. Leung

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 15:47
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/52; A; A61; A61P; A61P9/00; A61K; A61K38/00

Claims Analysis

Total Claims: 14
Claim 1
Independent Claim 25 words
An isolated DNA sequence comprising a nucleotide sequence encoding the amino acid sequence shown in FIG. 2 for bovine mature vascular endothelial cell growth factor.
Claim 2
Dependent Claim 25 words
An isolated DNA sequence comprising a nucleotide sequence encoding the amino acid sequence shown in FIG. 2 for bovine mature vascular endothelial cell growth factor.
Claim 3
Dependent Claim 26 words
An expression vector comprising the DNA sequence of claim 1 operably linked to control sequences that are operable in a host cell transformed with the vector.
Claim 4
Dependent Claim 9 words
The vector of claim 2 that is a plasmid.
Claim 5
Dependent Claim 11 words
A host cell transformed with the expression vector of claim 2.
Claim 6
Dependent Claim 9 words
The host cell of claim 4 that is eukaryotic.
Claim 7
Dependent Claim 9 words
The host cell of claim 5 that is mammalian.
Claim 8
Dependent Claim 25 words
An isolated DNA sequence comprising a nucleotide sequence encoding the amino acid sequence shown in FIG. 10 for human mature vascular endothelial cell growth factor.
Claim 9
Dependent Claim 25 words
An isolated DNA sequence comprising a nucleotide sequence encoding the amino acid sequence shown in FIG. 10 for human mature vascular endothelial cell growth factor.
Claim 10
Dependent Claim 26 words
An expression vector comprising the DNA sequence of claim 7 operably linked to control sequences that are operable in a host cell transformed with the vector.
Claim 11
Dependent Claim 9 words
The vector of claim 7 that is a plasmid.
Claim 12
Dependent Claim 11 words
A host cell transformed with the expression vector of claim 8.
Claim 13
Dependent Claim 9 words
The host cell of claim 10 that is eukaryotic.
Claim 14
Dependent Claim 9 words
The host cell of claim 10 that is mammalian.

References Cited (Backward Citations)

US4456550A Cited
US4721672A Cited
US5008196A Cited
EP0370989A2 Cited
US5240848A Cited
WO1990011084A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1997-07-25 1998-01-24 1998-07-26 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2001-07-25 2002-01-24 2002-07-26 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2005-07-25 2006-01-24 2006-07-26 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag